70209-59-5

Basic information

• Product Name: benzyl O-(2,3,4-tri-O-benzyl-α-L-fucopyranosyl)-(1<*>2)-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-(1<*>3)-O-(4,6-O-benzylidene-β-D-galactopyranosyl)-(1<*>4)-2-acetamido-3,6-di-O-benzyl-2-deoxy-α-D-glucopyranoside
• CAS NO: 70209-59-5
• Molecular Weight: 1680.99
• Mol File: 70209-59-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: benzyl O-(2,3,4-tri-O-benzyl-α-L-fucopyranosyl)-(1<*>2)-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-(1<*>3)-O-(4,6-O-benzylidene-β-D-galactopyranosyl)-(1<*>4)-2-acetamido-3,6-di-O-benzyl-2-deoxy-α-D-glucopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl O-(2,3,4-tri-O-benzyl-α-L-fucopyranosyl)-(1<*>2)-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-(1<*>3)-O-(4,6-O-benzylidene-β-D-galactopyranosyl)-(1<*>4)-2-acetamido-3,6-di-O-benzyl-2-deoxy-α-D-glucopyranoside(70209-59-5)
• EPA Substance Registry System: benzyl O-(2,3,4-tri-O-benzyl-α-L-fucopyranosyl)-(1<*>2)-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-(1<*>3)-O-(4,6-O-benzylidene-β-D-galactopyranosyl)-(1<*>4)-2-acetamido-3,6-di-O-benzyl-2-deoxy-α-D-glucopyranoside(70209-59-5)

Safety Data

• Hazardous Substances Data: 70209-59-5(Hazardous Substances Data)

Upstream product

• 53081-30-4 tetra-O-benzyl-α-D-galactosyl bromide 
• 70209-58-4 benzyl O-(2,3,4-tri-O-benzyl-α-L-fucopyranosyl)-(1<*>2)-O-(4,6-O-benzylidene-β-D-galactopyranosyl)-(1<*>4)-2-acetamido-3,6-di-O-benzyl-2-deoxy-α-D-glucopyranoside 

Relevant articles and documents

Bausteine von Oligosacchariden, XX. Synthese der Oligosaccharid-Determinanten der Blutgruppensubstanzen der Type 2 des ABH-Systems. Diskussion der &α-Glycosid-Synthese

The antigenic determinants of type 2 of blood-group substances A and B (23 and 24) as well as blood-group substance H (17) were synthesized by selective glycosidation reactions combined with a series of blocking and deblocking steps.The possibilities and optimization of the α-glycoside synthesis are discussed.In hemagglutination inhibition tests the synthetic haptens A and B of type 2 and type 1 show a similar selective inhibitory effect.In case of hapten H, however, great differences can be observed.Here the type 2 exhibited a strong inhibition activity, whereas type 1 only showed an extremly low activity.This leads to the conclusion that in the determinants of the ABH-system on the surface of erythrocytes the chemical structure of type 2 is predominating.